281 related articles for article (PubMed ID: 32041746)
1. Antibodies and B cells recognising citrullinated proteins display a broad cross-reactivity towards other post-translational modifications.
Kissel T; Reijm S; Slot LM; Cavallari M; Wortel CM; Vergroesen RD; Stoeken-Rijsbergen G; Kwekkeboom JC; Kampstra A; Levarht E; Drijfhout JW; Bang H; Bonger KM; Janssen G; van Veelen PA; Huizinga T; Scherer HU; Reth M; Toes R
Ann Rheum Dis; 2020 Apr; 79(4):472-480. PubMed ID: 32041746
[TBL] [Abstract][Full Text] [Related]
2. Different classes of anti-modified protein antibodies are induced on exposure to antigens expressing only one type of modification.
Kampstra ASB; Dekkers JS; Volkov M; Dorjée AL; Hafkenscheid L; Kempers AC; van Delft M; Kissel T; Reijm S; Janssen GMC; van Veelen PA; Bang H; Huizinga TWJ; Trouw LA; van der Woude D; Toes REM
Ann Rheum Dis; 2019 Jul; 78(7):908-916. PubMed ID: 31151934
[TBL] [Abstract][Full Text] [Related]
3. Breach of autoreactive B cell tolerance by post-translationally modified proteins.
Dekkers JS; Verheul MK; Stoop JN; Liu B; Ioan-Facsinay A; van Veelen PA; de Ru AH; Janssen GMC; Hegen M; Rapecki S; Huizinga TWJ; Trouw LA; Toes REM
Ann Rheum Dis; 2017 Aug; 76(8):1449-1457. PubMed ID: 28442530
[TBL] [Abstract][Full Text] [Related]
4. Impact of Posttranslational Modification in Pathogenesis of Rheumatoid Arthritis: Focusing on Citrullination, Carbamylation, and Acetylation.
Kwon EJ; Ju JH
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638916
[TBL] [Abstract][Full Text] [Related]
5. Cross-reactivity of IgM anti-modified protein antibodies in rheumatoid arthritis despite limited mutational load.
Reijm S; Kissel T; Stoeken-Rijsbergen G; Slot LM; Wortel CM; van Dooren HJ; Levarht NEW; Kampstra ASB; Derksen VFAM; Heer PO; Bang H; Drijfhout JW; Trouw LA; Huizinga TWJ; Rispens T; Scherer HU; Toes REM
Arthritis Res Ther; 2021 Sep; 23(1):230. PubMed ID: 34479638
[TBL] [Abstract][Full Text] [Related]
6. Evolution of anti-modified protein antibody responses can be driven by consecutive exposure to different post-translational modifications.
Volkov M; Kampstra ASB; van Schie KA; Kawakami A; Tamai M; Kawashiri S; Maeda T; Huizinga TWJ; Toes REM; van der Woude D
Arthritis Res Ther; 2021 Dec; 23(1):298. PubMed ID: 34876234
[TBL] [Abstract][Full Text] [Related]
7. Differential ACPA Binding to Nuclear Antigens Reveals a PAD-Independent Pathway and a Distinct Subset of Acetylation Cross-Reactive Autoantibodies in Rheumatoid Arthritis.
Lloyd KA; Wigerblad G; Sahlström P; Garimella MG; Chemin K; Steen J; Titcombe PJ; Marklein B; Zhou D; Stålesen R; Ossipova E; Lundqvist C; Ekwall O; Rönnelid J; Mueller DL; Karlsson MCI; Kaplan MJ; Skriner K; Klareskog L; Wermeling F; Malmström V; Grönwall C
Front Immunol; 2018; 9():3033. PubMed ID: 30662440
[TBL] [Abstract][Full Text] [Related]
8. A Comprehensive Evaluation of the Relationship Between Different IgG and IgA Anti-Modified Protein Autoantibodies in Rheumatoid Arthritis.
Grönwall C; Liljefors L; Bang H; Hensvold AH; Hansson M; Mathsson-Alm L; Israelsson L; Joshua V; Svärd A; Stålesen R; Titcombe PJ; Steen J; Piccoli L; Sherina N; Clavel C; Svenungsson E; Gunnarsson I; Saevarsdottir S; Kastbom A; Serre G; Alfredsson L; Malmström V; Rönnelid J; Catrina AI; Lundberg K; Klareskog L
Front Immunol; 2021; 12():627986. PubMed ID: 34093522
[TBL] [Abstract][Full Text] [Related]
9. Pathogenic Citrulline-Multispecific B Cell Receptor Clades in Rheumatoid Arthritis.
Titcombe PJ; Wigerblad G; Sippl N; Zhang N; Shmagel AK; Sahlström P; Zhang Y; Barsness LO; Ghodke-Puranik Y; Baharpoor A; Hansson M; Israelsson L; Skriner K; Niewold TB; Klareskog L; Svensson CI; Amara K; Malmström V; Mueller DL
Arthritis Rheumatol; 2018 Dec; 70(12):1933-1945. PubMed ID: 29927106
[TBL] [Abstract][Full Text] [Related]
10. Post-Translational Modifications of Proteins: Novel Insights in the Autoimmune Response in Rheumatoid Arthritis.
Carubbi F; Alunno A; Gerli R; Giacomelli R
Cells; 2019 Jun; 8(7):. PubMed ID: 31261953
[TBL] [Abstract][Full Text] [Related]
11. Recognition of Amino Acid Motifs, Rather Than Specific Proteins, by Human Plasma Cell-Derived Monoclonal Antibodies to Posttranslationally Modified Proteins in Rheumatoid Arthritis.
Steen J; Forsström B; Sahlström P; Odowd V; Israelsson L; Krishnamurthy A; Badreh S; Mathsson Alm L; Compson J; Ramsköld D; Ndlovu W; Rapecki S; Hansson M; Titcombe PJ; Bang H; Mueller DL; Catrina AI; Grönwall C; Skriner K; Nilsson P; Lightwood D; Klareskog L; Malmström V
Arthritis Rheumatol; 2019 Feb; 71(2):196-209. PubMed ID: 30152202
[TBL] [Abstract][Full Text] [Related]
12. Pitfalls in the detection of citrullination and carbamylation.
Verheul MK; van Veelen PA; van Delft MAM; de Ru A; Janssen GMC; Rispens T; Toes REM; Trouw LA
Autoimmun Rev; 2018 Feb; 17(2):136-141. PubMed ID: 29203292
[TBL] [Abstract][Full Text] [Related]
13. Carbamylation of vimentin is inducible by smoking and represents an independent autoantigen in rheumatoid arthritis.
Ospelt C; Bang H; Feist E; Camici G; Keller S; Detert J; Krämer A; Gay S; Ghannam K; Burmester GR
Ann Rheum Dis; 2017 Jul; 76(7):1176-1183. PubMed ID: 28183721
[TBL] [Abstract][Full Text] [Related]
14. [Autoantibodies and the autoreactive immune response : There is more to ACPA than ACPA].
Scherer HU
Z Rheumatol; 2020 Nov; 79(9):893-897. PubMed ID: 32970187
[TBL] [Abstract][Full Text] [Related]
15.
Vergroesen RD; Slot LM; van Schaik BDC; Koning MT; Rispens T; van Kampen AHC; Toes REM; Scherer HU
Front Immunol; 2019; 10():2092. PubMed ID: 31572358
[TBL] [Abstract][Full Text] [Related]
16. Generation and Characterization of Anti-Citrullinated Protein Antibody-Producing B Cell Clones From Rheumatoid Arthritis Patients.
Germar K; Fehres CM; Scherer HU; van Uden N; Pollastro S; Yeremenko N; Hansson M; Kerkman PF; van der Voort EIH; Reed E; Maassen H; Kwakkenbos MJ; Bakker AQ; Klareskog L; Malmström V; de Vries N; Toes REM; Lundberg K; Spits H; Baeten DL
Arthritis Rheumatol; 2019 Mar; 71(3):340-350. PubMed ID: 30277007
[TBL] [Abstract][Full Text] [Related]
17. Single cell cloning and recombinant monoclonal antibodies generation from RA synovial B cells reveal frequent targeting of citrullinated histones of NETs.
Corsiero E; Bombardieri M; Carlotti E; Pratesi F; Robinson W; Migliorini P; Pitzalis C
Ann Rheum Dis; 2016 Oct; 75(10):1866-75. PubMed ID: 26659717
[TBL] [Abstract][Full Text] [Related]
18. The Role of Posttranslational Protein Modifications in Rheumatological Diseases: Focus on Rheumatoid Arthritis.
Mastrangelo A; Colasanti T; Barbati C; Pecani A; Sabatinelli D; Pendolino M; Truglia S; Massaro L; Mancini R; Miranda F; Spinelli FR; Conti F; Alessandri C
J Immunol Res; 2015; 2015():712490. PubMed ID: 26090496
[TBL] [Abstract][Full Text] [Related]
19. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis.
Lac P; Saunders S; Tutunea-Fatan E; Barra L; Bell DA; Cairns E
J Autoimmun; 2018 May; 89():75-81. PubMed ID: 29242008
[TBL] [Abstract][Full Text] [Related]
20. Antibody responses to de novo identified citrullinated fibrinogen peptides in rheumatoid arthritis and visualization of the corresponding B cells.
Joshua V; Schobers L; Titcombe PJ; Israelsson L; Rönnelid J; Hansson M; Catrina AI; Pruijn GJ; Malmström V
Arthritis Res Ther; 2016 Dec; 18(1):284. PubMed ID: 27906052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
